Noxilizer is pioneering the development and commercialization of a unique and superior room temperature sterilization technology that will revolutionize two major markets — life science manufacturing and hospital reprocessing.

For life science manufacturing applications, the Noxilizer technology is used today to sterilize single-use medical devices, bioresorbable implants, collagen scaffolds and drug-device combination products like prefilled syringes. Noxilizer’s advantages in this market include:

• Better penetration into complex medical devices;
• No aeration time required leading to improved efficiency; and
• Proven material compatibility with medical device materials, therapeutic molecules and biomaterials.

Today, the company provides contract sterilization services to medical device companies. In 2012, Noxilizer will have sterilization units available for sale and placement in a company’s manufacturing facility or research and development division. A complete product line is in development.

In hospital reprocessing, Noxilizer is developing a system for sensitive, high-tech equipment that is increasingly used in minimally-invasive surgical procedures. The potential advantages over existing methods include: more gentle and lethal sterilization, increased worker safety, improved efficiency due to shorter overall processing times and the ability to sterilize long lumens.

The company was founded in 2004 and is privately held. Noxilizer is located at the University of Maryland Baltimore County Technology Center in Baltimore, MD.